Presence of corticotrophin-releasing factor and/or tyrosine hydroxylase in cells of a neural brain-testicular pathway that are labelled by a transganglionic tracer

Journal of Neuroendocrinology

Volumn 20, Issue 2, 2008, Pages 173-181

  James, P ^a   Rivier, C ^a   Lee, S ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Catecholamine; CRF; Hypothalamus; Testosterone; Tracing

Indexed keywords

BENZODIAZEPINE RECEPTOR; CORTICOTROPIN RELEASING FACTOR; GONADOTROPIN; LUTEINIZING HORMONE; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TESTOSTERONE; TRACER; TYROSINE 3 MONOOXYGENASE;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG DISTRIBUTION; ENZYME ACTIVITY; ENZYME LOCALIZATION; HORMONE RESPONSE; IMMUNOFLUORESCENCE; MALE; NEUROENDOCRINOLOGY; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PSEUDORABIES HERPETOVIRUS; RAT; SOLITARY TRACT NUCLEUS; STRESS; STRIA TERMINALIS; TESTOSTERONE RELEASE; THALAMUS MIDLINE NUCLEUS;

ANIMALS; BRAIN; CATECHOLAMINES; CORTICOTROPIN-RELEASING HORMONE; HERPESVIRUS 1, SUID; INJECTIONS; MALE; MESENCEPHALON; NEURAL PATHWAYS; NEURONS; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RHOMBENCEPHALON; TESTIS; TESTOSTERONE; TISSUE DISTRIBUTION; TYROSINE 3-MONOOXYGENASE;

EID: 38549173717     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2007.01630.x     Document Type: Article

References (54)

1. Selvage DJ, Rivier C. Leydig cell activity is regulated by a neural pathway between the hypothalamus and the testes that does not include the pituitary. Recent Res Dev Endocrinol 2004: 97-114.
2. Hayes FJ, DeCruz S, Seminara SB, Boepple PA, Crowley WF Jr. Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion. J Clin Endocrinol Metab 2001; 86: 53-58.
3. Ellis GB, Desjardins C. Male rats secrete luteinizing hormone and testosterone episodically. Endocrinology 1982; 110: 1618-1627.
4. Campos MB, Chiocchio SR, Calandra RS, Ritta MN. Effect of bilateral denervation of the immature rat testis on testicular gonadotropin receptors and in vitro androgen production. Neuroendocrinology 1993; 57: 189-194.
5. Mizunuma H, DePalatis LR, McCann SM. Effect of unilateral orchidectomy on plasma FSH concentration: Evidence for a direct neural connection between testes and CNS. Neuroendocrinology 1983; 37: 291-296.
6. Turnbull AV, Rivier C. Inhibition of gonadotropin-induced testosterone secretion by the intracerebroventricular injection of interleukin-1 beta in the male rat. Endocrinology 1997; 138: 1008-1013.
7. Lee S, Miselis R, Rivier C. Anatomical and functional evidence for a neural hypothalamic-testicular pathway that is independent of the pituitary. Endocrinology 2002; 143: 4447-4454.
8. Gerendai I, Toth IE, Boldogkoi Z, Medveczky I, Halasz B. Central nervous system structures labelled from the testis using the transsynaptic viral tracing technique. J Neuroendocrinol 2000; 12: 1087-1095.
9. Selvage DJ, Lee SY, Parsons LH, Seo DO, Rivier CL. A hypothalamic-testicular neural pathway is influenced by brain catecholamines, but not testicular blood flow. Endocrinology 2004; 145: 1750-1759.
10. Selvage DJ, Rivier C. Importance of the paraventricular nucleus of the hypothalamus as a component of a neural pathway between the brain and the testes that modulates testosterone secretion independently of the pituitary. Endocrinology 2003; 144: 594-598.
11. Ogilvie KM, Held Hales K, Roberts ME, Hales DB, Rivier C. The inhibitory effect of intracerebroventricularly injected interleukin 1beta on testosterone secretion in the rat: Role of steroidogenic acute regulatory protein. Biol Reprod 1999; 60: 527-533.
12. Ogilvie K, Rivier C. The intracerebroventricular injection of interleukin-1beta blunts the testosterone response to human chorionic gonadotropin: Role of prostaglandin- and adrenergic-dependent pathways. Endocrinology 1998; 139: 3088-3095.
13. West LA, Horvat RD, Roess DA, Barisas BG, Juengel JL, Niswender GD. Steroidogenic acute regulatory protein and peripheral-type benzodiazepine receptor associate at the mitochondrial membrane. Endocrinology 2001; 142: 502-505.
14. Hauet T, Yao ZX, Bose HS, Wall CT, Han Z, Li W, Hales DB, Miller WL, Culty M, Papadopoulos V. Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into leydig cell mitochondria. Mol Endocrinol 2005; 19: 540-554.
15. Herman M, Rivier C. Activation of a neural brain-testicular pathway rapidly lowers Leydig cell levels of the steroidogenic acute regulatory protein and the peripheral-type benzodiazepine receptor while increasing levels of neuronal nitric oxide synthase. Endocrinology 2006; 147: 624-633.
16. Damber JE, Janson PO. The effects of LH, adrenaline and noradrenaline on testicular blood flow and plasma testosterone concentrations in anaesthetized rats. Acta Endocrinol (Copenh) 1978; 88: 390-396.
17. Ungerstedt U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand Suppl 1971; 367: 1-48.
18. Koob GF. Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry 1999; 46: 1167-1180.
19. Sahuque LL, Kullberg EF, McGeehan AJ, Kinder JR, Hicks MP, Blanton MG, Janak PH, Olive MF. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: Role of CRF receptor subtypes. Psychopharmacology (Berl) 2006; 186: 122-132.
20. Jasnow AM, Davis M, Huhman KL. Involvement of central amygdalar and bed nucleus of the stria terminalis corticotropin-releasing factor in behavioral responses to social defeat. Behav Neurosci 2004; 118: 1052-1061.
21. Williamson M, Bingham B, Viau V. Central organization of androgen-sensitive pathways to the hypothalamic-pituitary-adrenal axis: implications for individual differences in responses to homeostatic threat and predisposition to disease. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 1239-1248.
22. Card GL, Knowles P, Laman H, Jones N, McDonald NQ. Crystal structure of a gamma-herpesvirus cyclin-cdk complex. EMBO J 2000; 19: 2877-2888.
23. Card JP, Rinaman L, Lynn RB, Lee BH, Meade RP, Miselis RR, Enquist LW. Pseudorabies virus infection of the rat central nervous system: ultrastructural characterization of viral replication, transport, and pathogenesis. J Neurosci 1993; 13: 2515-2539.
24. Card JP, Rinaman L, Schwaber JS, Miselis RR, Whealy ME, Robbins AK, Enquist LW. Neurotropic properties of pseudorabies virus: Uptake and transneuronal passage in the rat central nervous system. J Neurosci 1990; 10: 1974-1994.
25. Valentino RJ, Kosboth M, Colflesh M, Miselis RR. Transneuronal labeling from the rat distal colon: Anatomic evidence for regulation of distal colon function by a pontine corticotropin-releasing factor system. J Comp Neurol 2000; 417: 399-414.
26. Card JP, Enquist LW, Moore RY. Neuroinvasiveness of pseudorabies virus injected intracerebrally is dependent on viral concentration and terminal field density. J Comp Neurol 1999; 407: 438-452.
27. Selvage DJ, Parsons L, Rivier C. Role played by brainstem neurons in regulating testosterone secretion via a direct neural pathway between the hypothalamus and the testes. Endocrinology 2006; 147: 3070-3075.
28. Cunningham ET Jr, Sawchenko PE. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol 1988; 274: 60-76.
29. Palkovits M, Zaborszky L, Feminger A, Mezey E, Fekete MI, Herman JP, Kanyicska B, Szabo D. Noradrenergic innervation of the rat hypothalamus:eXperimental biochemical and electron microscopic studies. Brain Res 1980; 191: 161-171.
30. Plotsky PM. Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. Endocrinology 1987; 121: 924-930.
31. Pacak K, Palkovits M, Kopin IJ, Goldstein DS. Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity: In vivo microdialysis studies. Front Neuroendocrinol 1995; 16: 89-150.
32. Melia KR, Duman RS. Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system. Proc Natl Acad Sci USA 1991; 88: 8382-8386.
33. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981; 213: 1394-1397.
34. Reyes BA, Glaser JD, Van Bockstaele EJ. Ultrastructural evidence for co-localization of corticotropin-releasing factor receptor and mu-opioid receptor in the rat nucleus locus coeruleus. Neurosci Lett 2007; 413: 216-221.
35. Clark FM, Proudfit HK. The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: Anatomical evidence that A5 neurons modulate nociception. Brain Res 1993; 616: 200-210.
36. Palkovits M, Mezey E, Skirboll LR, Hokfelt T. Adrenergic projections from the lower brainstem to the hypothalamic paraventricular nucleus, the lateral hypothalamic area and the central nucleus of the amygdala in rats. J Chem Neuroanat 1992; 5: 407-415.
37. Liposits Z, Phelix C, Paull WK. Adrenergic innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A combined light and electron microscopic immunocytochemical study. Histochemistry 1986; 84: 201-205.
38. Akana SF, Chu A, Soriano L, Dallman MF. Corticosterone exerts site-specific and state-dependent effects in prefrontal cortex and amygdala on regulation of adrenocorticotropic hormone, insulin and fat depots. J Neuroendocrinol 2001; 13: 625-637.
39. Aronsson M, Fuxe K, Dong Y, Agnati LF, Okret S, Gustafsson JA. Localization of glucocorticoid receptor mRNA in the male rat brain by in situ hybridization. Proc Natl Acad Sci USA 1988; 85: 9331-9335.
40. Fuxe K, Wikstrom AC, Okret S, Agnati LF, Harfstrand A, Yu ZY, Granholm L, Zoli M, Vale W, Gustafsson JA. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology 1985; 117: 1803-1812.
41. Arriza JL, Simerly RB, Swanson LW, Evans RM. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron 1988; 1: 887-900.
42. Herman JP, Ostrander MM, Mueller NK, Figueiredo H. Limbic system mechanisms of stress regulation: Hypothalamo-pituitary-adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 1201-1213.
43. Makino S, Gold PW, Schulkin J. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res 1994; 640: 105-112.
44. van der Kooy D, Koda LY, McGinty JF, Gerfen CR, Bloom FE. The organization of projections from the cortex, amygdala, and hypothalamus to the nucleus of the solitary tract in rat. J Comp Neurol 1984; 224: 1-24.
45. Canteras NS, Simerly RB, Swanson LW. Organization of projections from the medial nucleus of the amygdala: A PHAL study in the rat. J Comp Neurol 1995; 360: 213-245.
46. Smith SM, Vale WW. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci 2006; 8: 383-395.
47. Meloni EG, Gerety LP, Knoll AT, Cohen BM, Carlezon WA Jr. Behavioral and anatomical interactions between dopamine and corticotropin-releasing factor in the rat. J Neurosci 2006; 26: 3855-3863.
48. Sawchenko PE, Swanson LW, Grzanna R, Howe PR, Bloom SR, Polak JM. Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 1985; 241: 138-153.
49. Dimitrov EL, Dejoseph MR, Brownfield MS, Urban JH. Involvement of neuropeptide Y Y1 receptors in the regulation of neuroendocrine corticotropin releasing hormone neuronal activity. Endocrinology 2007; 148: 3666-3673.
50. Riche D, De Pommery J, Menetrey D. Neuropeptides and catecholamines in efferent projections of the nuclei of the solitary tract in the rat. J Comp Neurol 1990; 293: 399-424.
51. Sawchenko PE, Arias C, Bittencourt JC. Inhibin beta, somatostatin, and enkephalin immunoreactivities coexist in caudal medullary neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 1990; 291: 269-280.
52. Williamson M, Viau V. Androgen receptor expressing neurons that project to the paraventricular nucleus of the hypothalamus in the male rat. J Comp Neurol 2007; 503: 717-740.
53. Bartness TJ, Song CK, Demas GE. SCN efferents to peripheral tissues: implications for biological rhythms. J Biol Rhythms 2001; 16: 196-204.
54. Gerendai I, Wiesel O, Toth IE, Boldogkoi ZS, Rusvai M, Halasz B. Identification of neurones of the brain and spinal cord involved in the innervation of the ductus deferens using the viral tracing method. Int J Androl 2003; 26: 91-100.